Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome

Abstract

BackgroundA number of registry studies have reported suboptimal adherence to guidelines for cardiovascular prevention during the first year after acute myocardial infarction (AMI). However, only a few studies have addressed long-term secondary prevention after AMI. This study evaluates prevention guideline adherence and outcome of guideline-directed secondary prevention in patients surviving 2 years after AMI.MethodsPatients aged 18–85 years at the time of their index AMI were consecutively identified from hospital discharge records between July 2010 and December 2011 in Gothenburg, Sweden. All patients who agreed to participate in the study (16.2%) were invited for a structured interview, physical examinations and laboratory analysis 2 years after AMI. Guideline-directed secondary preventive goals were defined as optimally controlled blood pressure, serum cholesterol, glucose, regular physical activity, smoking cessation and pharmacological treatment.ResultsThe mean age of the study cohort (n = 200) at the index AMI was 63.0 ± 9.7 years, 79% were men. Only 3.5% of the cohort achieved all six guideline-directed secondary preventive goals 2 years after infarction. LDL < 1.8 mmol/L was achieved in 18.5% of the cohort, regular exercise in 45.5% and systolic blood pressure <140 mmHg in 57.0%. Anti-platelet therapy was used by 97% of the patients, beta-blockers by 83.0%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers by 76.5% and statins by 88.5%. During follow-up, non-fatal adverse cardiovascular events (cardiac hospitalization, recurrent acute coronary syndrome, angina pectoris, new percutaneous coronary intervention, new onset of atrial fibrillation, post-infarct heart failure, pacemaker implantation, stroke/transient ischemic attack (TIA), cardiac surgery and cardiac arrest) occurred in 47% of the cohort and readmission due to cardiac causes in 30%.ConclusionsOur data showed the failure of secondary prevention in our daily clinical practice and high rate of non-fatal adverse cardiovascular events 2 years after AMI.

Secondary prevention of coronary heart disease: a cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

“…2 In this context, secondary prevention of CHD, especially using pharmacological therapy, has been effective in reducing recurrence of events, decreasing morbidity and mortality and improving quality of life. 3 National and international guidelines recommend long-term use of evidence-based medication for management of CHD, such as use of acetylsalicylic acid (ASA), beta blockers, angiotensin-converting enzyme inhibitors (ACEI) and statins, as first-line therapy; or other antiplatelet medication, angiotensin receptor blocker (ARB) or fibrate when first-line therapy is contraindicated. [3][4][5][6][7][8] Despite this well-established knowledge, not all patients with CHD are able to obtain the standard treatment endorsed by the guidelines.…”

Natriuretic and Inflammatory Biomarkers as Risk Predictors of Heart Failure in Middle-Aged Men From the General Population: A 21-Year Follow-Up

“…In a study from our group only 3.5% of patients achieved six pre-specifi ed prevention goals 2 years after acute myocardial infarction and non-fatal cardiovascular events occurred in 46.5% of the participants. 100 A reasonable question is whether the above-described changes in cardiovascular risk factors and diseases have an impact on the incidence and risk profi le of HF in the contemporary era with gradually improved primary and secondary cardiovascular prevention (despite remaining suboptimal).…”

Cardiac rehabilitation goal attainment after myocardial infarction with versus without diabetes: A nationwide registry study

“…The purpose of cardiac rehabilitation (CR) is to decrease morbidity and mortality, and improve quality of life post MI [13,14]. Guidelines for CR uniformly recommend behavioural/lifestyle interventions targeting smoking cessation, regular exercise training and increased daily physical activity, maintaining a healthy body weight, optimal control of risk factors (blood pressure, cholesterol and glucose control), and adherence to cardioprotective drug therapies [15].…”